When it comes to treating difficult diseases like cancer, researchers have been leaning more and more toward the concept of precision medicine. It means finding a unique course of treatment that is tailored toward a cancer tumor's particular characteristics. One of the drugs, Keytruda, made by Merck, requires a diagnostic test to scan for proteins in the tumor that indicate it might work, while the other, Opdivo, made by Bristol-Myers Squibb, is marketed more broadly and approved for use without the additional test.
The search for a cancer cure is ongoing, but recent research may have given us an edge in the fight. Welcome to WatchMojo News, the weekly series from WatchMojo.com where we break down news stories that might be on your radar.
